Y. Najean

M. Delin, Y. Najean, M. Boulard, 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Androgen therapy of aplastic anaemia--a prospective study of 352 cases.

A. Pecking, Y. Najean, M. L. Danvic, 2009, Scandinavian journal of haematology.

Refractory anemia with excess of blast cells: Prognostic factors and effect of treatment with androgens or cytosine arabinoside. Results of a prospective trial in 58 patients

A. Pecking, Y. Najean, 1979 .

Polycythaemia vera in young people: an analysis of 58 cases diagnosed before 40 years

P. Mugnier, Y. Najean, C. Dresch, 1987, British journal of haematology.

[Anemia of kidney failure treated by periodical hemodialysis. III. The effect of splenectomy. A retrospective study of 25 cases].

O. Messian, Y. Najean, 1983, Presse medicale.

[Anemia of chronic renal insufficiency. II. Effect of androgen therapy in 17 subjects treated with periodic hemodialysis].

Y. Najean, P. Aubert, S. Delons, 1983, Presse medicale.

Is the thrombopoietin assay useful for differential diagnosis of thrombocytopenia? Analysis of a cohort of 160 patients with thrombocytopenia and defined platelet life span.

C. Chomienne, I. Gouin-Thibault, B. Cassinat, 2001, Clinical chemistry.

Present results of the treatment of myelodysplastic syndromes with low-dose cytosine arabinoside. Preliminary results of a cooperative protocol (38 patients) and review of the literature.

J. Gris, P. Fenaux, C. Chomienne, 1987, Acta haematologica.

Chronic pure thrombocytopenia in elderly patients. An aspect of the myelodysplastic syndrome

T. Lecompte, Y. Najean, 1989, Cancer.

Prognostic value of in vitro bone marrow culture in refractory anaemia with excess of myeloblasts.

A. Faille, Y. Najean, C. Dresch, 2009, Scandinavian journal of haematology.

Phase III multicenter randomized trial in RAEB patients of more than 60 years of age: Ara-C 3mg/m2 versus symptomatic treatment

S. Chevret, C. Chomienne, Y. Najean, 1994 .

Prognosis scoring system in refractory anemia with excess of blast (RAEB)

S. Chevret, C. Chomienne, Y. Najean, 1994 .

Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia.

P. Fenaux, M. Toubert, L. Degos, 1994, Leukemia.

The site of platelet destruction in thrombocytopenic purpura as a predictive index of the efficacy of splenectomy

M. Toubert, Y. Najean, J. Rain, 1991, British journal of haematology.

[Practical value of the study of erythrocyte kinetics by in vitro labelling with Cr 51 in autoimmune hemolytic anemia].

Y. Najean, B. Habibi, 1971, La Presse medicale.

Cell culture studies in 19 cases of refractory aneamia: comparison of clinical data with in vivo erythrokinetic studies.

A. Faille, Y. Najean, C. Dresch, 2009, Scandinavian journal of haematology.

Treatment of polycythemia vera with hydroxyurea

J. Goldberg, L. Wasserman, J. Laszlo, 1984, American journal of hematology.

Effect of Antilymphocyte Globulin on Granulocyte Precursors in Aplastic Anaemia

A. Faille, E. Gluckman, Y. Najean, 1979, British journal of haematology.

Influence of therapy on causes of death in polycythemia vera.

S. Balcerzak, J. Goldberg, L. Wasserman, 1981, Transactions of the Association of American Physicians.

The body venous haematocrit ratio and its use for calculating total blood volume from fractional volumes

Y. Najean, F. Deschrywer, 2004, European Journal of Nuclear Medicine.

Measurement of intestinal progression of a meal and its residues in normal subjects and patients with functional diarrhoea by a dual isotope technique.

J. Bernier, Y. Najean, R. Jian, 1984, Gut.

Effect of combination chemotherapy, duration of methotrexate administration, and Patient's age on methotrexate pharmacokinetics

C. Gisselbrecht, M. Marty, M. Boiron, 2004, Cancer Chemotherapy and Pharmacology.

Genetic thrombocytopenia with autosomal dominant transmission: a review of 54 cases

T. Lecompte, Y. Najean, 1990, British journal of haematology.

The site of destruction of autologous 111In‐labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies

C. Billotey, Y. Najean, J. Rain, 1997, British journal of haematology.

[Gallium-67 scintigraphy in malignant lymphoma].

C. Gisselbrecht, C. Bris, P. Brice, 1993, Presse medicale.

Bone marrow cell kinetics and culture in chronic and subacute myelomonocytic leukemia. Physiopathological interpretation and prognostic importance.

A. Faille, Y. Najean, C. Dresch, 1980, Leukemia research.

An analysis of prognostic factors in preleukemia: Interest of bone marrow scintigraphy

C. Chomienne, Y. Najean, C. Dresch, 1984, American journal of hematology.

Prognostic value of the combined suicide level of granulocyte progenitors and the labelling index of precursors in preleukemic states and oligoblastic leukemias.

Y. Najean, C. Dresch, J. Metral, 1983, Leukemia research.

Incidence Of Myelofibrosis Following Treatment Of Primary Polycythaemia By Venesection

T. Pearson, Y. Najean, M. Messdmezy, 1995, British journal of haematology.

Chromosome studies in polycythemia vera patients.

R. Berger, A. Bernheim, G. Flandrin, 1984, Cancer genetics and cytogenetics.

Blood cells in nuclear medicine, part I

M. Hardeman, Y. Najean, 1984, Developments in Nuclear Medicine.

Treatment of polycythemia vera: use of 32P alone or in combination with maintenance therapy using hydroxyurea in 461 patients greater than 65 years of age. The French Polycythemia Study Group.

Y. Najean, J. Rain, 1997, Blood.

Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias".

Y. Najean, C. Dresch, J. Rain, 1996, Leukemia & lymphoma.

[Development of polycythemia to myelofibrosis. Monitoring by the assay of the procollagen III amino-propeptide].

Y. Najean, O. Poirier, J. Arrago, 1984, Presse medicale.

R. A. Dudley, S. Lewis, L. Garby, 1971, Blood.

[Blood physiology].

Y. Najean, 1958, Gazette medicale de France.

[Gougerot-Sjögren's syndrome and pemphigus. Parallel development of the dryness syndrome and auto-immune dermatosis].

A. Pecking, Y. Najean, D. Wallach, 1979, Annales de dermatologie et de venereologie.

Treatment of polycythemia vera: the use of hydroxyurea and pipobroman in 292 patients under the age of 65 years.

Y. Najean, J. Rain, 1997, Blood.

Hydroxyurea suicide study of the kinetic heterogeneity of colony forming cells in human bone marrow.

A. Faille, Y. Najean, C. Dresch, 1979, Experimental hematology.

[Are the androgens effective in the treatment of medullary aplasias?].

B. Dreyfus, J. Dormont, J. Soulier, 1967, La Presse medicale.

[Septicemic state due to Moraxella lwoffi].

Y. Najean, M. Deparis, A. Sarrazin, 1956, La Presse medicale.

[Very long complete remissions of acute leukemia. 65 cases of acute leukemia that lasted longer than 4 years].

M. Boiron, M. Weil, J. Tanzer, 1970, La Presse medicale.

Histological and urinary reactivity of monoclonal antibody 1be12 in bladder carcinoma. Purification of the antigen from urine

E. Osinaga, P. Teillac, F. Calvo, 1991, International journal of cancer.

The use of 75Se-methionin for the in vivo study of platelet kinetics.

N. Ardaillou, Y. Najean, 2009, Scandinavian journal of haematology.

Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.

J. Goldberg, L. Wasserman, S. Landaw, 1981, The New England journal of medicine.

Iron metabolism--a study of different kinetic models in normal conditions.

N. Ardaillou, Y. Najean, C. Dresch, 1967, The American journal of physiology.

The influence of circadian variations in plasma iron on the measure of plasma iron turnover

Y. Najean, C. Dresch, P. Colonna, 1977, European Journal of Nuclear Medicine.

Anatomo-Pathological Analysis of Human Tumors with 3 Anti Carcino-Embryonic Antigen Monoclonal Antibodies

A. Faille, C. Rimbaut, D. Buffe, 1984 .

Use of Monoclonal Antibodies for Precipitin Reactions

Y. Najean, P. Pouletty, C. Mihaesco, 1984 .

The mechanism of thrombocytopenia in patients with HIV infection.

Y. Najean, J. Rain, 1994, The Journal of laboratory and clinical medicine.

Red cell kinetics in thalassaemia intermedia: its use for a prospective prognosis

R. Girot, T. Henni, Y. Najean, 1985, British journal of haematology.

Partial splenectomy in homozygous beta thalassaemia.

Y. Révillon, R. Girot, M. de Montalembert, 1990, Archives of disease in childhood.

In contrast with other myeloid series, and particularly the red cell series, relatively few methods enable to quantify platelet production. So, in clinical practice, only rough (and

Y. Najean, 1984 .

Methods of Quantification of Platelet Production in Man. A Critical Analysis

Y. Najean, 1984 .

[REGULATION OF ERYTHROPOIESIS].

Y. Najean, 1965, La Presse medicale.

Evaluation of 216 four‐year survivors of acute leukemia

M. Boiron, G. Auclerc, G. Flandrin, 1973, Cancer.

[Treatment of the intial stages of acute lymphoblastic leukemia by a combination of prednisone-vincristine-rubidomycin].

M. Boiron, M. Weil, C. Jacquillat, 1967, Pathologie et biologie.

In vitro 51Cr and 32P-DFP labeling of granulocytes in man.

Y. Najean, C. Dresch, J. Beauchet, 1971, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Rubidomycin. A new agent active in the treatment of acute lymphoblastic leukaemia.

M. Boiron, M. Weil, J. Tanzer, 1966, Lancet.

[Trial of treatment of acute lymphoblastic and myeloblastic leukemias by a new antibiotic: rubidomycin (RP 13,057). Study of 61 cases].

M. Boiron, M. Weil, J. Tanzer, 1967, La Presse medicale.

Kinetic Studies of 51Cr and DF32P Labelled Granulocytes

J. Bauchet, Y. Najean, C. Dresch, 1975, British journal of haematology.

[A new agent active in the treatment of acute leukemia: cytosine arabinoside].

M. Boiron, M. Weil, C. Jacquillat, 1966, La Presse medicale.

Acute leukemia and myelodysplasia in polycythemia vera. A clinical study with long‐term follow‐up

M. Daniel, Y. Najean, C. Dresch, 1988, Cancer.

[Disorders of the utilization of hemoglobin iron during the developent of Hodgkin's disease].

N. Ardaillou, Y. Najean, C. Dresch, 1967, Nouvelle revue francaise d'hematologie.

RISK FACTORS FOR THROMBOSIS IN POLYCYTHAEMIA VERA

Y. Najean, P. Cornett, H. Wold, 1988, British journal of haematology.

Platelet kinetics in human immunodeficiency virus induced thrombocytopenia

Y. Najean, V. Dufour, Zoher Bel‐Ali, 1987, American journal of hematology.

Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology

T. Pearson, S. Lewis, G. Barosi, 1995, British journal of haematology.

Identifying abnormal parathyroid glands in the thyroid uptake area using technetium-99m-sestamibi and factor analysis of dynamic structures.

A. Aurengo, C. Billotey, M. Toubert, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Beta-Thromboglobulin and Platelet Factor 4 in Polycythemia and Thrombocythemia

Y. Najean, O. Poirier, 1984 .

The clinical significance of beta-thromboglobulin and platelet factor-4 in polycythaemic patients.

F. Lokiec, Y. Najean, O. Poirier, 2009, Scandinavian journal of haematology.

[Study of the kinetics of polynuclear cells after labeling "in vitro" with radioactive chromium. I. Critical study of the method and results obtained in normal subjects].

Y. Najean, C. Dresch, 1967, Nouvelle revue francaise d'hematologie.

The Platelet Destruction Site in Thrombocytopenic Purpuras

N. Ardaillou, Y. Najean, C. Dresch, 1967, British journal of haematology.

Red cell and platelet kinetics in chronic cytopenias following transplantation.

C. Billotey, Y. Najean, J. Rain, 1997, Hematology and Cell Therapy.

Androgen therapy in aplastic anaemia: a comparative study of high and low-doses and of 4 different androgens. French Cooperative Group for the Study of Aplastic and Refractory Anemias.

Y. Najean, refractory anaemias, 2009, Scandinavian journal of haematology.

Prognostic factors in acquired aplastic anemia. A study of 352 cases.

A. Pecking, Y. Najean, 1979, The American journal of medicine.

Long-term follow-up in patients with aplastic anemia: A study of 137 androgen-treated patients surviving more than two years

Y. Najean, 1981 .

[Treatment of polycythemia with 32P with or without hydroxyurea maintenance therapy. Preliminary results in 237 elderly and high vascular risk subjects studied since 1980].

M. Toubert, Y. Najean, J. Rain, 1993, Presse medicale.

[Treatment of polycythemia vera with hydroxyurea or pipobroman. Efficacy and toxicity analysed from a protocol of 96 patients under 65 years of age. Le Groupe d'Etude des Polyglobulies].

Y. Najean, 1992, Presse medicale.

Two different in vitro growth patterns for erythroid precursors in 18 patients with pure erythrocytosis.

Y. Najean, A. Chedeville, A. Eberlin, 2009, Scandinavian journal of haematology.

[Diphosphoglyceromutase deficiency: new cases associated with erythrocytosis].

F. Galactéros, R. Rosa, M. Calvin, 1984, Nouvelle revue francaise d'hematologie.

Survival and distribution of platelets.

N. Ardaillou, Y. Najean, 1965, Minerva nucleare.

Risks and benefits of splenectomy in myelofibrosis: an analysis of 39 cases.

Y. Najean, J. Rain, P. Clot, 1994, Nouvelle revue francaise d'hematologie.

Diagnostic value of bone marrow imaging with 111indium‐transferring and 99mtechnetium‐colloids in myelofibrosis

C. Chomienne, Y. Najean, N. Vigneron, 1985, American journal of hematology.

Clinical significance of serum pro‐collagen III in chronic myeloproliferative disorders

Y. Najean, O. Poirier, J. Arrago, 1990, European journal of haematology.

Type III aminoterminal propeptide of procollagen in some haematological malignancies.

C. Chomienne, Y. Najean, O. Poirier, 2009, Scandinavian journal of haematology.

Bone marrow culture in aplastic anaemia

A. Barrett, A. Faille, Y. Najean, 2005 .

Methods of Evaluating the Sequestration Site of Red Cells Labelled with 5ICr: a Review of 96 Cases

R. Cacchione, Y. Najean, C. Dresch, 1975, British journal of haematology.

Chronic myelocytic leukemia with a masked Ph1 chromosome.

A. Bernheim, J. Tanzer, Y. Najean, 1977, The New England journal of medicine.

Hereditary Thrombocytopenias in Childhood

T. Lecompte, Y. Najean, 1995, Seminars in thrombosis and hemostasis.

Pregnancy and paroxysmal nocturnal hemoglobinuria.

H. Fernandez, J. Pons, P. Solal-Céligny, 1988, Archives of internal medicine.

The ‘spent’phase of polycythaemia vera: hypersplenism in the absence of myelofibrosis

Y. Najean, C. Dresch, J. Rain, 1984, British journal of haematology.

Erythropoietin concentration in the serum from patients with primary thrombocythaemia

M. Toubert, Y. Najean, M. Schlageter, 1995, European journal of haematology.

Influence of long-term androgen therapy on growth: an analysis of 18 cases of aplastic anemia in children.

B. Bourliere, Y. Najean, 1987, American journal of diseases of children.

[Prognosis of hematopoietic dysplasia (author's transl)].

A. Faille, Y. Najean, C. Dresch, 1977, Nouvelle revue francaise d'hematologie; blood cells.

Unwanted side effect of hydroxyurea.

Y. Najean, 1996, Annals of hematology.

The very long-term evolution of polycythemia vera: an analysis of 318 patients initially treated by phlebotomy or 32P between 1969 and 1981.

Y. Najean, J. Rain, Rainer Jd, 1997, Seminars in hematology.

Erythrokinetic Studies in Hairy‐Cell Leukaemia

G. Flandrin, H. Castro-Malaspina, Y. Najean, 1979, British journal of haematology.

Radioimmunoassay of immunoreactive erythropoietin as a clinical tool for the classification of polycythaemias.

M. Toubert, Y. Najean, M. Schlageter, 1990, Nouvelle revue francaise d'hematologie.

Erythrokinetic Studies in Myelofibrosis: Their Significance for Prognosis

H. Castro-Malaspina, Y. Najean, C. Dresch, 1978, British journal of haematology.

Prognosis of myeloid metaplasia with myelofibrosis.

M. Laval-Jeantet, C. Jacquillat, J. Briére, 1976, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

[Gougerot-Sjögren syndrome. Functional study of the salivary glands by scintigraphy].

F. Rocher, A. Pecking, Y. Najean, 1984, Presse medicale.

Epidemiological data in polycythaemia vera: a study of 842 cases.

C. Billotey, Y. Najean, J. Rain, 1998, Hematology and cell therapy.

Long-term follow-up in patients with aplastic anemia. A study of 137 androgen-treated patients surviving more than two years. Joint Group for the Study of Aplastic and Refractory Anemias.

Y. Najean, 1981, The American journal of medicine.

Platelet survival studies in patients with vascular diseases

M. Wacquet, Y. Najean, N. Vigneron, 1979, European journal of clinical investigation.

Gastric juice in pernicious anemia

J. Bernier, Y. Najean, A. Lambling, 1961, The American Journal of Digestive Diseases.

[Hypochromic anemias due to voluntarily induced hemorrhages. Lasthénie de Ferjol's syndrome].

Y. Najean, J. Bernard, J. Rain, 1967, La Presse medicale.

"Acquired" red cell enzyme defects in hematological diseases.

G. Löhr, Y. Najean, K. Blume, 1974, Clinica chimica acta; international journal of clinical chemistry.

[Study of the effect of androgen therapy during bone marrow insufficiency].

G. Schaison, C. Jacquillat, Y. Najean, 1966, La Presse medicale.

Multicentre Double-Blind Clinical Trial of Iron Protein Succinylate in Comparison With Iron Sulfate in the Treatment of Iron Deficiency Anaemia

A. Scotti, Y. Najean, G. Acuto, 1995 .

[Indication for splenectomy in idiopathic thrombopenic purpura].

N. Ardaillou, Y. Najean, 1971, La Presse medicale.

Gastric emptying and intragastric distribution of lipids in man

Y. Najean, N. Vigneron, R. Jian, 1982, Digestive Diseases and Sciences.

A new method for measuring simultaneously the phagocytic and bactericidal capacity of human leukocytes.

Y. Najean, C. Dresch, M. Grange, 1975, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

[Vascular complications of polycythemia].

Y. Najean, C. Dresch, O. Poirier, 1983, Annales de medecine interne.

Induction of high-affinity GM-CSF receptors during all-trans retinoic acid treatment of acute promyelocytic leukemia.

M. Toubert, L. Degos, Y. Najean, 1994, Leukemia.

Granulopoiesis : studies of bone marrow culture in chronic granulocytopenia and comparison with granulocyte kinetics.

A. Faille, Y. Najean, C. Dresch, 1977, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Cytogenetic studies on acute nonlymphocytic leukemias following polycythemia vera.

R. Berger, A. Bernheim, G. Flandrin, 1984, Cancer genetics and cytogenetics.

Percentage of free serum prostate-specific antigen: a new tool in the early diagnosis of prostatic cancer.

O. Cussenot, P. Meria, D. Rastel, 1996, European journal of cancer.

Safety problems related to chloramphenicol and thiamphenicol therapy

G. Tognoni, A. Yunis, Y. Najean, 1981 .

Aplastic anemia and thiamphenicol.

Y. Najean, 1981, Haematologica.

Why still prescribe chloramphenicol in 1983?

Y. Najean, E. Baumelou, 1983, Blut.

Kinetics of indium-oxine labelled red cells in haemolytic anaemias

Y. Pommier, C. Chomienne, Y. Najean, 2004, European Journal of Nuclear Medicine.

111 Indium labelling of red cells: its clinical use in haemolytic anaemias.

Y. Pommier, Y. Najean, F. Deschrywer, 1986, Journal of clinical pathology.

[Aplasia caused by busulfan in chronic myeloid leukemia].

M. Boiron, J. Tanzer, C. Jacquillat, 1967, Nouvelle revue francaise d'hematologie.

Radioimmunodetection of lymph node invasion in prostatic cancer. The use of iodine 123 (123I)‐labeled monoclonal anti‐prostatic acid phosphatase (PAP) 227 A F(ab′l)2 antibody fragments in vivo

P. Teillac, A. Duc, J. Saccavini, 1989, Cancer.

Measurement ofintestinal progression ofamealandits residues innormal subjects andpatients withfunctional diarrhoea byadualisotope technique

J. Bernier, Y. Najean, R. Jian, 1984 .

Kinetics of erythropoiesis in hemodialysis-patients (hd pts) on recombinant erythropoietin (rhuepo) treatment

A. Moynot, T. Drüeke, B. Varet, 1989 .

[Treatment of acute lymphoblastic leukemia by rubidomycin].

M. Boiron, M. Weil, J. Tanzer, 1967, Pathologie et biologie.

Chronic myelocytic leukaemia with unusual (27 years) complete remission terminating in acute undifferentiated leukaemia: a clinical and karyotypic study.

J. Tanzer, M. Lessard, F. Sigaux, 1991, Leukemia.

[Study of the progression of an ordinary meal in the human small bowel by a scintigraphic method (author's transl)].

J. Bernier, A. Pecking, Y. Najean, 1979, Gastroenterologie clinique et biologique.

Letter: Red-cell phosphofructokinase deficiency.

M. Reviron, Y. Najean, M. Meienhofer, 1974, The New England journal of medicine.

Models of erythropoiesis and clinical diagnosis

Y. Najean, C. Dresch, C. Monot, 1975 .

In Vivo Platelet Kinetics in 31 Diabetic Patients

P. Passa, Y. Najean, O. Poirier, 1978, Thrombosis and Haemostasis.

Refractory anemia with excess of blast cells: Prognostic factors and effect of treatment with androgens or cytosine arabinoside. Results of a prospective trial in 58 patients

A. Pecking, Y. Najean, 1979, Cancer.

An analysis of the effect of random and ageing mechanisms on the survival of platelets.

Y. Najean, N. Balitrand, E. Dassin, 1976, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Use of [75Se]-methionine as a tracer of thrombocytopoiesis. II- Kinetics in normal rats and in platelet disorders in man: a new approach.

N. Ardaillou, Y. Najean, E. Dassin, 1978, Biochemical and biophysical research communications.

The use of 75Se-methionine as a tracer of thrombocytopoiesis. I. In vivo incorporation of the tracer into platelet proteins: a biochemical study.

Y. Najean, E. Dassin, 1979, Acta haematologica.

RUBIDOMYCIN: A New Agent Active in the Treatment of Acute Lymphoblastic Leukæmia

M. Boiron, M. Weil, J. Tanzer, 1966 .

[Effects of hydroxyurea in chronic myeloid leukemia. Preliminary study].

M. Boiron, M. Weil, J. Tanzer, 1966, La Presse medicale.

[Development and prognosis of idiopathic pancytopenia. Study of 116 cases].

M. Boiron, Y. Najean, C. Dresch, 1965, Nouvelle revue francaise d'hematologie.

Myelosuppression in polycythemia vera: Chemotherapy or radiotherapy?

Y. Najean, C. Dresch, 2004, Blut.

[Study of granulocyopoiesis by autoradiography of the bone marrow in vitro. I. Observations on normal subjects and in granulocytopenias].

A. Faille, Y. Najean, R. Ruvidić, 1970, Nouvelle revue francaise d'hematologie.